TY - JOUR
T1 - Changes in leukemic cell nuclei revealed by differential scanning calorimetry
AU - Rogalińska, Małgozata
AU - Góralski, Paweł
AU - Kobylińska, Agnieszka
AU - Błoński, Jerzy Z.
AU - Hanausek, Margaret
AU - Walaszek, Zbigniew
AU - Piekarski, Henryk
AU - Robak, Tadeusz
AU - Kilianska, Zofia M.
N1 - Funding Information:
This work was partly supported by KBN grant 6PO5A 01821 and by grant 505/446 from the University of Łódź.
PY - 2005/1
Y1 - 2005/1
N2 - Using differential scanning calorimetry we analyzed the thermal profiles of nuclei from normal and B-cell chronic lymphocytic leukemia mononuclear cells. Intact nuclear fraction of normal mononuclear cells is characterized by four thermal transitions, i.e., at 60, 70, 83 and 103°C. Leukemic nuclear samples revealed the transitions at 67 and 83°C, however, in more aggressive stage of the disease additional thermal peaks at 76 and 93°C were observed. Our very preliminary results revealed that mononuclear cell nuclear fraction from blood of patients responding to the used therapy, i.e., cladribine alone or its combination with mitoxantrone and cyclophosphamide indicates decrease (or even loss) of transition at 93°C concomitant with increase of transition at 76°C. A complementary study showed that in mononuclear cells of patients who appeared to be sensitive to chemotherapy the decrease of antiapoptotic Bcl-2 protein expression and signs of apoptotic morphology were observed.
AB - Using differential scanning calorimetry we analyzed the thermal profiles of nuclei from normal and B-cell chronic lymphocytic leukemia mononuclear cells. Intact nuclear fraction of normal mononuclear cells is characterized by four thermal transitions, i.e., at 60, 70, 83 and 103°C. Leukemic nuclear samples revealed the transitions at 67 and 83°C, however, in more aggressive stage of the disease additional thermal peaks at 76 and 93°C were observed. Our very preliminary results revealed that mononuclear cell nuclear fraction from blood of patients responding to the used therapy, i.e., cladribine alone or its combination with mitoxantrone and cyclophosphamide indicates decrease (or even loss) of transition at 93°C concomitant with increase of transition at 76°C. A complementary study showed that in mononuclear cells of patients who appeared to be sensitive to chemotherapy the decrease of antiapoptotic Bcl-2 protein expression and signs of apoptotic morphology were observed.
KW - B-CLL
KW - Bcl-2 protein morphology
KW - Differential scanning calorimetry
KW - Nuclear fraction
UR - http://www.scopus.com/inward/record.url?scp=12744271998&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=12744271998&partnerID=8YFLogxK
U2 - 10.1080/10428190412331283170
DO - 10.1080/10428190412331283170
M3 - Article
C2 - 15621789
AN - SCOPUS:12744271998
VL - 46
SP - 121
EP - 128
JO - Leukemia and Lymphoma
JF - Leukemia and Lymphoma
SN - 1042-8194
IS - 1
ER -